iiinova — where your digital self keeps evolving

salomepinho.bsky.social

@salomepinho.bsky.social

34 followers 32 following 3 posts

Posts Replies Media

salomepinho.bsky.social @salomepinho.bsky.social · 05/01/2026

www.nature.com/articles/s41... Mucosa glycans as key drivers of gut inflammation and #IBD #glycotime @i3suporto.bsky.social

Mucosal glycans: key drivers of the development of inflammatory bowel disease and a potential new therapeutic target - Nature Reviews Gastroenterology & Hepatology

Glycans are essential components of the gut mucosa that modulate epithelial barrier integrity, host–microbiota interactions and gut immune response. This Review discusses the role of mucosal glycans i...

salomepinho.bsky.social @salomepinho.bsky.social · 10/11/2025

An amazing week at University of Alberta 🇨🇦with plenty of #glycotime! A big thanks to @glycocode.bsky.social , @giaglyco.bsky.social and to @glyconet.bsky.social for the kind invitation!! Also great to see inspiring glyco-researchers that marked a generation

salomepinho.bsky.social @salomepinho.bsky.social · 30/04/2025

academic.oup.com/ecco-jcc/art... Happy to share our most recent publication on how T cells glycosylation mediates #IBD progression to colorectal cancer defining the risk of colitis-associated cancer. #glycotime Great work @eduardalgomes.bsky.social @i3suporto.bsky.social @GlycanTrigger

academic.oup.com

T-cell branched glycosylation as a mediator of colitis-associated colorectal cancer progression: a potential new risk biomarker in inflammatory bowel disease

AbstractBackground and Aims. Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract, established as a risk facto